Amgen Profile

170.81
USD 3.85  2.2%
19%
5%

Exercise or conversion by Bonanni Fabrizio of 4000 shares of Amgen subject to Rule 16b-3

Amgen insider trading alert for exercise of nqso (right to buy) by Bonanni Fabrizio, Senior VP Manufacturing, on April 21, 2018. This event was filed by Amgen Inc with SEC on 2005-02-01. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

Amgen Summary

Amgen (AMGN) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 20,800 people. Amgen is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Mega-Cap' category with current market capitalization of 114.65 B. Amgen conducts business under Healthcare sector and is part of Pharmaceuticals And Biosciences industry. This company has 668.27 M outstanding shares of which 8.03 M shares are presently shorted by private and institutional investors with about 2.71 trading days to cover. AMGEN currently holds about 41.68 B in cash with 8.51 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 57.84.
Check Amgen Probability Of Bankruptcy

Ownership Allocation (%)

Target Price Odds Analysis

Below OddsHorizonTargetAbove Odds
about 14.77%30 days 170.81  about 85.08%
Based on normal probability distribution, the odds of Amgen to move above current price in 30 days from now is about 85.08% (This Amgen probability density function shows the probability of Amgen Stock to fall within a particular range of prices over 30 days) .

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Bank Of MontrealCommon Shares2.2 M372.6 M
Chevy Chase Trust Holdings IncCommon Shares581.5 K99.1 M
View Amgen Diagnostics

Selected Amgen Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Amgen Against Markets

Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
Financial Distress (0 to 100%)
< 41% 
Equity ratings for Amgen are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. Amgen Inc. was founded in 1980 and is headquartered in Thousand Oaks, California. Amgen operates under Biotechnology classification in USA and traded on NASDAQ. It employs 20800 people. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameAmgen
ChairmanRobert BradwayView All
Thematic Classifications
Active Investing Ideas
showing 2 out of 5 themes  View All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Bond Rating
Specialization
Healthcare, Pharmaceuticals And Biosciences
InstrumentUSA Stock View All
RegionNorth America
LocationCALIFORNIA, U.S.A
Business AddressOne Amgen Center Drive
Foreign Associates
ExchangeNASDAQ
CIK Number00318154.0
ISINUS0311621009
CUSIP031162100
SectorHealthcare
IndustryPharmaceuticals And Biosciences
BenchmarkDOW
Websitewww.amgen.com
Contact Number805 447 1000
CurrencyUSD - US Dollar

Recommendations

Amgen Analyst Recommendations
Target PriceAdvice# of Analysts
183.83Hold12Odds
Amgen current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Amgen Analyst Advice  

Earnings

Amgen Earnings Estimates
EPSEstimate Date
Quarterly Estimate2.99April 27, 2017
Amgen normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate  

Directors

Amgen Corporate Directors
Frank Herringer Independent Director
Francois Carbonnel Independent Director
Rebecca Henderson Independent Director, Ph.D
Check also Trending Equities. Please also try Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.